Keywords: ppl, bayer, link, up, aat, development, via

PPL, Bayer link up on AAT development via $40M agreement

Article | 17 August 2000

PPL Therapeutics and Bayer are to collaborate on the development ofan aerosolized formulation of PPL's transgenically-produced alpha1-antitrypsin, initially for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Aspirin

Bayer

Go to drug listing